Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 5.07 is in line with its 5-year average of 5.58, near the low end of its 5-year range (3.82–10.17).
As of the fiscal period ended Tuesday, June 30, 2026. 1.64% above its 12-month average of 4.99.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.07.
CURRENT RATIO
5.07
CURRENT RATIO AVG TTM
4.99
CURRENT RATIO AVG 3Y
5.04
CURRENT RATIO AVG 5Y
5.58
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+1.64%
CURRENT VS 3Y AVG
+0.61%
CURRENT VS 5Y AVG
-9.11%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 530 covered companies
CURRENT VS SECTOR MEDIAN
+51.04%
vs the sector median at left
Market Cap
$1.38B
Current Ratio
35.85
TTM Avg
18.03
3Y Avg
18.03
5Y Avg
18.03
Market Cap
$1.40B
Current Ratio
11.11
TTM Avg
12.01
3Y Avg
12.01
5Y Avg
12.01
Market Cap
$1.47B
Current Ratio
3.02
TTM Avg
3.13
3Y Avg
2.94
5Y Avg
3.03
Market Cap
$1.33B
Current Ratio
14.16
TTM Avg
12.98
3Y Avg
15.39
5Y Avg
17.04
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Inhibrx Biosciences Inc. (INBX) | $1.40B | 5.07 | 4.99 | 5.04 | 5.58 |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.38B | 35.85 | 18.03 | 18.03 | 18.03 |
| AnaptysBio, Inc. (ANAB)vs › | $1.43B | 5.61 | 9.29 | 11.65 | 16.84 |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.40B | 11.11 | 12.01 | 12.01 | 12.01 |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.36B | 11.09 | 7.43 | 12.87 | 13.60 |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.47B | 3.02 | 3.13 | 2.94 | 3.03 |
| Braveheart Bio, Inc. (BRVE)vs › | $1.45B | N/A | N/A | N/A | N/A |
| ArriVent BioPharma, Inc. (AVBP)vs › | $1.33B | 14.16 | 12.98 | 15.39 | 17.04 |
| GH Research PLC (GHRS)vs › | $1.51B | 28.70 | 25.68 | 28.23 | 39.79 |
| Kardigan, Inc. (KARD)vs › | $1.29B | 8.72 | 9.20 | 9.20 | 9.20 |
Current Ratio
5.07
Quick Ratio
5.07
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 5.07 |
| 2026-03-31 | 6.46 |
| 2025-12-31 | 3.93 |
| 2025-09-30 | 4.49 |
| 2025-06-30 | 4.98 |
| 2025-03-31 | 5.12 |
| 2024-12-31 | 3.94 |
| 2024-09-30 | 4.70 |
| 2024-06-30 | 6.20 |
| 2024-03-31 | 3.82 |
| 2023-12-31 | 5.25 |
| 2023-09-30 | 10.16 |
| 2023-06-30 | 6.49 |
| 2023-03-31 | 7.47 |
| 2022-12-31 | 10.17 |
| 2022-09-30 | 6.05 |
| 2022-06-30 | 7.50 |
| 2022-03-31 | 7.48 |
| 2021-12-31 | 6.20 |
| 2021-09-30 | 4.73 |
| 2021-06-30 | 6.06 |
| 2021-03-31 | 4.07 |
| 2020-12-31 | 4.21 |
| 2020-09-30 | 3.80 |
| 2020-06-30 | 0.30 |
| 2020-03-31 | 0.13 |
| 2019-12-31 | 0.76 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 2.30 |
| 2019-03-31 | 0.60 |
| 2018-12-31 | 0.35 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 1.73 |
